Author

Michael J. Vjecha

Observed names: M J Vjecha, M Vjecha, M Vjecha (13489972), M. Vjecha, M.J. Vjecha, Michael J Vjecha, Michael Vjecha

Observed institutions: University of North Carolina at Chapel Hill, Parkland Health & Hospital System, University of Minnesota, United States Department of Veterans Affairs, Burnet Institute, University Hospitals of Cleveland, Veterans Health Administration, The Alfred Hospital, UNSW Sydney, Institute of Clinical Research, Washington DC VA Medical Center, Rutgers New Jersey Medical School, Monash University, Case Western Reserve University

OpenAlex ID: A5107879989

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

2015 · Daniel D. Murray, Kazuo Suzuki, et al. · PLoS ONE · 2,754

PDF

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons

2010 · E.J. Wright, B. Grund, et al. · Neurology · 189

PDF

Factors Associated With Plasma IL-6 Levels During HIV Infection

2015 · Álvaro H. Borges, Jemma L. O'Connor, et al. · The Journal of Infectious Diseases · 175

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection

2016 · Álvaro H. Borges, Jemma L. O'Connor, et al. · The Journal of Infectious Diseases · 132

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans

1994 · A Okwera, F Byekwaso, et al. · The Lancet · 106

Factors Associated with D-Dimer Levels in HIV-Infected Individuals

2014 · Álvaro H. Borges, Jemma L. O’Connor, et al. · PLoS ONE · 88

PDF

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

2010 · Amit C Achhra, Janaki Amin, et al. · AIDS · 84

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

2017 · Jemma O'Connor, Michael J Vjecha, et al. · The Lancet HIV · 69

PDF

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

PDF

Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals

2017 · Daniel D. Murray, Kazuo Suzuki, et al. · Scientific Reports · 35

PDF

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 33

PDF

HIV-1 Risk and Vaccine Acceptability in the Ugandan Military

1997 · D. L. Hom, J. L. Johnson, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 33

No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

2018 · Edwina J. Wright, Birgit Grund, et al. · AIDS · 23

Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.

1997 · A Okwera, J L Johnson, et al. · PubMed · 22

Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials

2016 · Gregg S Larson, Cate Carey, et al. · Clinical Trials · 21

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 20

PDF

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

2017 · Sarah L Pett, Ken M Kunisaki, et al. · Open Forum Infectious Diseases · 19

PDF

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

2017 · Dominic E Dwyer, Ruth Lynfield, et al. · Open Forum Infectious Diseases · 18

PDF

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

PDF

Determinants of IL‐6 levels during HIV infection

2014 · Álvaro H Borges, Jemma L O'Connor, et al. · Journal of the International AIDS Society · 13

PDF

Haemoglobin and Anaemia in the Smart Study

2010 · the INSIGHT SMART Study Group, Amanda Mocroft, et al. · Antiviral Therapy · 13

Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect

2013 · for the INSIGHT SMART Study Group, Birgit Grund, et al. · Journal of NeuroVirology · 12

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

2022 · Thomas A Rasmussen, Sunil K Ahuja, et al. · Clinical Infectious Diseases · 11

PDF

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

2018 · Lone Simonsen, Elizabeth Higgs, et al. · Clinical Infectious Diseases · 9

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

PDF

Works count: 28

Citation count: 3,963

H-index: 18

I10-index: 23